CCLA Investment Management’s Pfizer PFE Stock Holding History

CCLA Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-44,615	Closed	-$1.25M	–	67
2024 Q3	$1.25M	Hold	44,615	–	–	0.02%	68
2024 Q2	$1.25M	Hold	44,615	–	–	0.02%	68
2024 Q1	$1.24M	Hold	44,615	–	–	0.02%	69
2023 Q4	$1.28M	Buy	44,615 +5,528	+14%	+$167K	0.02%	70
2023 Q3	$1.3M	Buy	39,087 +10,773	+38%	+$381K	0.02%	71
2023 Q2	$1.04M	Sell	28,314 -17,693	-38%	-$689K	0.02%	72
2023 Q1	$1.88M	Sell	46,007 -9,265	-17%	-$400K	0.04%	73
2022 Q4	$2.83M	Hold	55,272	–	–	0.06%	65
2022 Q3	$2.42M	Buy	+55,272	New	+$2.69M	0.06%	67
2022 Q1	$2.87M	Sell	55,394 -45,527	-45%	-$2.36M	0.05%	67
2021 Q4	$5.96M	Buy	100,921 +38,757	+62%	+$1.92M	0.1%	62
2021 Q3	$2.67M	Hold	62,164	–	–	0.04%	67
2021 Q2	$2.44K	Hold	62,164	–	–	0.03%	68
2021 Q1	$2.25M	Sell	62,164 -19,323	-24%	-$686K	0.05%	66
2020 Q4	$3M	Sell	81,487 -1,051,926	-93%	-$38.6M	0.07%	61
2020 Q3	$39.4M	Sell	1,133,413 -224,052	-17%	-$7.86M	1.07%	47
2020 Q2	$42.1M	Buy	+1,357,465	New	+$46.1M	1.32%	34

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CCLA Investment Management's PFE Position: Q4 2024 in Review

CCLA Investment Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 44,615 shares — an estimated $1.25M sold.

CCLA Investment Management first reported a position in PFE in Q2 2020 and held it in 17 quarters. The position peaked at $42.1M in Q2 2020. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

CCLA Investment Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
CCLA Investment Management sold 44,615 Pfizer shares in Q4 2024, an estimated $1.25M.
CCLA Investment Management first reported a position in Pfizer in Q2 2020 and held it in 17 quarters.
CCLA Investment Management's Pfizer position peaked at $42.1M in Q2 2020.
2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on CCLA Investment Management's 13F filing for Q4 2024, filed 14 Jan 2025.